OOIR: Observatory of International Research

Papers

(The H4-Index of Neurology-Neuroimmunology & Neuroinflammation is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases	150
A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions	149
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia	130
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment	120
Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology	117
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis	105
Relapsing and Immune-Responsive Paroxysmal Jaw Clonus With Blepharospasm and Sialorrhea Associated With D2R Autoantibodies	100
Antibody-Negative Autoimmune Encephalitis	85
CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis	85
T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis	82
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis	72
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod	72
Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood	70
Pro-Inflammatory Molecules Implicated in Multiple Sclerosis Divert the Development of Human Oligodendrocyte Lineage Cells	68
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD	67
Relapsing-Remitting Immunotherapy Responsive Small-Fiber Neuropathy	66
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis	61
Should We Measure CSF Complement Levels in Patients With MOGAD?	61
Synaptic Protein Loss in Extracellular Vesicles Reflects Brain and Retinal Atrophy in People With Multiple Sclerosis	61
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America	60
Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder	59
TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency	55
CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity	49
Acute Paresthesia and Ataxia in a Child	48
Peripheral Immune Profiles Predict ALS Progression in an Age- and Sex-Dependent Manner	48

Encephalitis and Myelitis in a Young Woman	47
Treatment With Erythropoietin for Patients With Optic Neuritis	46
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8 ⁺ Regulatory T Cells	46
Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway	46
Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis	45
Toward Precision Phenotyping of Multiple Sclerosis	44
Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria	44
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection	44
Increased Intracranial Pressure in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease	43
Retinal Optical Coherence Tomography in Neuromyelitis Optica	43
Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy	43
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA _B R Antibodies	43
Immunotherapy-Responsive Neuropathic Pain and Allodynia in a Patient With Glycine Receptor Autoantibodies	43
Proteomics Analysis Moves the Needle by Generating Clinical Diagnostic Markers	42
Epstein-Barr Virus in the Cerebrospinal Fluid and Blood Compartments of Patients With Multiple Sclerosis and Controls	42
Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease	42
Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders	41
The Role of Complement Activation in IgM M-Protein–Associated Neuropathies	41
Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice	41
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis	41
Clinical Manifestations and Treatment Responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy	41